Review: The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications
This follows its role as a cytoprotection mediator transmitting the mucosal integrity maintenance to other organs therapy [1,2,3,4,5,6,7,8,9,10,11,15,27,28,29,30,33,109,124,125] in consideration of the regular dietary taking (dietary nitrate as an important source of NO in mammals [252]), and nitrate-nitrite-NO pathway (and swallowed nitrite) resulting with high NO concentration in the stomach [253]
However, tirzepatide is proven across thousands of patients in rigorous global Phase 3 trials and is FDA-approved and available today
The clock usually starts ticking from the date of your injury or when you reasonably should have discovered the link between your injury and the drug